GlassScriptPhysician profile
Lam D Nguyen
NPI 1902082258
$11,318.29
in general payments reported to CMS, 2019-2025
51 companies · $991 in 2025
The $991 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,827 · 2020: $1,555 · 2021: $1,703 · 2022: $2,405 · 2023: $1,026 · 2024: $1,811 · 2025: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,094 · Travel and Lodging: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,094.32 |
| Travel and Lodging | $733.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,019.99 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Vanta Adaptivestim |
| Abbott Laboratories | $1,546.80 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $918.85 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $882.76 | 2019-2025 | Belbuca, Xtampza |
| Abbvie INC. | $881.25 | 2021-2025 | |
| Boston Scientific Corporation | $578.00 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Nevro Corp. | $571.89 | 2019-2023 | Senza |
| Grt US Holding, INC. | $455.06 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $445.61 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $329.59 | 2019-2022 | |
| Allergan, INC. | $318.75 | 2019-2021 | |
| Averitas Pharma INC. | $304.18 | 2023-2025 | Qutenza |
| Scilex Pharmaceuticals INC. | $300.19 | 2019-2023 | Ztlido |
| Daiichi Sankyo INC. | $135.39 | 2019 | |
| Redhill Biopharma INC. | $116.73 | 2020-2022 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lam Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.